DPP-4 inhibitors

This publication has 60 references indexed in Scilit:

• Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 Diabetes
  Diabetes, 2007
• Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes
  Diabetes Care, 2007
• Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial
  Diabetes, Obesity and Metabolism, 2007
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
  Published by Elsevier ,2006
• DPP-4 inhibitors and their potential role in the management of type 2 diabetes
  International Journal Of Clinical Practice, 2006
• Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
  Diabetologia, 2006
• Biologic actions and therapeutic potential of the proglucagon-derived peptides
  Nature Clinical Practice Endocrinology & Metabolism, 2005
• Acute and Chronic Effects of the Incretin Enhancer Vildagliptin in Insulin-Resistant Rats
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• GIP as a Potential Therapeutic Agent?
  Hormone and Metabolic Research, 2004
• Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
  Critical Reviews in Clinical Laboratory Sciences, 2003